Gene · 8438
Papers1,865
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,865
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Modification Effects of Homologous Recombination Repair Gene Polymorphisms on the Associations Between Urinary Metals and Breast Cancer Risk. | Biol Trace Elem Res | 2025 | 38720017 | PubTator, text mining | PubMed |
A phase II study evaluating safety and efficacy of niraparib in patients with previously treated homologous recombination defective metastatic esophageal/gastroesophageal junction/proximal gastric adenocarcinoma. | Front Oncol | 2024 | 39640282 | PubTator, text mining | PubMed |
| Gene expression profile analysis of severe influenza-based modulation of idiopathic pulmonary fibrosis. | Eur J Med Res | 2024 | 39420432 | PubTator, text mining | PubMed |
| Withdrawal: Cooperativity of Mus81·Mms4 with Rad54 in the resolution of recombination and replication intermediates. | J Biol Chem | 2024 | 39383702 | PubTator, text mining | PubMed |
| KNTC1 functions as a potential biomarker and oncogene regulating proliferation, migration and apoptosis in gastric cancer. | Int Immunopharmacol | 2024 | 39362011 | PubTator, text mining | PubMed |
| Homologous recombination deficiency gene panel analysis results in synchronous endometrial and ovarian cancers. | Rev Assoc Med Bras (1992) | 2024 | 39356959 | PubTator, text mining | PubMed |
| Disparate requirements for RAD54L in replication fork reversal. | Nucleic Acids Res | 2024 | 39315725 | PubTator, text mining | PubMed |
| Malignant melanoma complicated with cataract and secondary glaucoma: A case report. | Oncol Lett | 2024 | 39268160 | PubTator, text mining | PubMed |
| Targeting proliferating cell nuclear antigen enhances ionizing radiation-induced cytotoxicity in prostate cancer cells. | Prostate | 2024 | 39219052 | PubTator, text mining | PubMed |
| Genomic landscape of early-stage prostate adenocarcinoma in Mexican patients: an exploratory study. | Discov Oncol | 2024 | 39196408 | PubTator, text mining | PubMed |
| Identification of Key Genes Associated with Polycystic Ovarian Syndrome and Endometrial and Ovarian Cancer through Bioinformatics. | J Hum Reprod Sci | 2024 | 39091436 | PubTator, text mining | PubMed |
| Case report: Remarkable response to later-line surufatinib in an adult patient with liver metastatic of pancreatoblastoma. | Front Pharmacol | 2024 | 38948477 | PubTator, text mining | PubMed |
| Author Correction: Rad54 and Rdh54 occupy spatially and functionally distinct sites within the Rad51-ssDNA presynaptic complex. | EMBO J | 2024 | 38834854 | PubTator, text mining | PubMed |
| The translocation activity of Rad54 reduces crossover outcomes during homologous recombination. | Nucleic Acids Res | 2024 | 38828785 | PubTator, text mining | PubMed |
| Retraction Note: RAD54L promotes progression of hepatocellular carcinoma via the homologous recombination repair pathway. | Funct Integr Genomics | 2024 | 38736002 | PubTator, text mining | PubMed |
| Expression of DNA Repair Genes in Ewing Sarcoma. | Cancer Diagn Progn | 2024 | 38707718 | PubTator, text mining | PubMed |
| Characterization of a G2M checkpoint-related gene model and subtypes associated with immunotherapy response for clear cell renal cell carcinoma. | Heliyon | 2024 | 38617927 | PubTator, text mining | PubMed |
| Overexpression of RAD54L attenuates osteoarthritis by suppressing the HIF-1α/VEGF signaling pathway: Bioinformatics analysis and experimental validation. | PLoS One | 2024 | 38593124 | PubTator, text mining | PubMed |
| Homologous recombination contributes to the repair of acetaldehyde-induced DNA damage. | Cell Cycle | 2024 | 38571319 | PubTator, text mining | PubMed |
| RNA m5C modification upregulates E2F1 expression in a manner dependent on YBX1 phase separation and promotes tumor progression in ovarian cancer. | Exp Mol Med | 2024 | 38424195 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8438/papers?page=4